Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|September 24, 2008
ASA404: update on drug developmentFarah Rehman, Gordon Rustin
The Journal of Steroid Biochemistry and Molecular Biology|May 3, 2005
Aromatase inhibition by 15-deoxy-prostaglandin J(2) (15-dPGJ(2)) and N-(4-hydroxyphenyl)-retinamide (4HPR) is associated with enhanced ceramide productionWilliam J Andrews, Georgia Winnett, Farah Rehman, et al.
Breast (Edinburgh, Scotland)|June 10, 2023
Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of lifeSarah-Jane F Stewart, Joanna Slodkowska-Barabasz, Lucy McGeagh, et al.
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|December 20, 2025
Supporting women with adherence to adjuvant endocrine therapy (SWEET): feasibility study of the HT&Me interventionLucy McGeagh, Sarah-Jane Stewart, Ruth Norris, et al.
Breast Cancer Research and Treatment|January 19, 2019
Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experienceNicolò Matteo Luca Battisti, Belinda Kingston, Judy King, et al.
The Journal of Liquid Biopsy|June 22, 2026
Development of a LiDia-SEQ™ platform compatible breast cancer panel and testing with metastatic breast cancer patient samples: A rapid, sample-to-result, fully integrated next-generation sequencing (NGS)-based platform, LiDia-SEQ, for use at the point-of-needMohammadali Yavari Ramsheh, Raquel L Fraccari, Rossitza Christova, et al.
Breast Cancer Research and Treatment|June 7, 2021
Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patientsGeorgios Nteliopoulos, Karen Page, Allison Hills, et al.
Cancer Discovery|March 25, 2024
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer CellsDalia Rosano, Emre Sofyali, Heena Dhiman, et al.
Trials|November 27, 2025
Improving outcomeS for Women diagnosed with early breast cancer through adhErence to adjuvant Endocrine Therapy (SWEET): study protocol for a pragmatic randomised control trial of a patient-centred intervention to improve adherence to endocrine therapy in early breast cancerLucy McGeagh, Alice Walker, Louise Hiller, et al.
JCO Precision Oncology|May 1, 2024
Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With Breast CancerJacqueline A Shaw, Karen Page, Evie Wren, et al.
Pageof 2